Immune response of bivalent mRNA booster in adults who had received a primary series of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike (NDV-HXP -S)

Immune response of bivalent mRNA booster in adults who had received a primary series of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike (NDV-HXP -S)

Introduction: An inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike (NDV-HXP-S) is a novel inactivated COVID-19 vaccine platform. With possibilities for local manufacturing utilizing existing egg-based production technologies, NDV-HXP-S vaccines could be introduced i...

Full description

Bibliographic Details
Main Authors: Dr Viravarn Luvira, Assoc. Prof. Weerapong Phumratanaprapin, Assoc. Prof. Saranath Lawpoolsri, Dr. Anan Jongkaewwattana, Dr. Sira Nanthapisal, Assist Prof Sant Muangnoicharoen, Assist Prof Supitcha Kamolratanakul, Miss Yupa Sabmee, Miss Chatnapa Duangdee, Assoc Prof Benjaluck Phonrat, Prof Punnee Pitisuttithum
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224006982

Internet

http://www.sciencedirect.com/science/article/pii/S1201971224006982

Similar Items